Application of EQ-5D-5L questionnaire in patients suffering from urinary incontinence [Aplicación del cuestionario EQ-5D-5L en pacientes que padecen incontinencia urinaria]
MetadataShow full item record
Background Urinary incontinence is associated with reduced quality of life and given the high prevalence of people with this condition, it could be useful to know the impact of having urinary incontinence on physical, psychological and social aspects. The Spanish value set of EQ-5D was used to assign single scores to the EQ-5D-5L health states. EQ-5D-5L is a health-related quality of life questionnaire, which allows assessing health status. The aim of this study was to provide normative values of EQ-5D-5L in a population sample with urinary incontinence. Study design Cross-sectional study. Methods A total of 965 people with urinary incontinence (297 men and 668 women) were included in this study. EQ-5D-5L index, VAS and health status are showed in the current study considering gender, age group, region, marital status, smoking status, net monthly incomes of household and educational level. Results Higher prevalence was observed in women (69.22%) compared with men (30.78%). Mean (SD) EQ-5D-5L utility index and VAS score were 0.58 (0.40) and 53.91 (22.16), respectively, for overall population. The 16.1% (155 people) reported perfect health status (11111). The utility equivalent to set values 55555 was not reported by anyone. Conclusion This study provides normative values of EQ-5D-5L in a Spanish population sample with urinary incontinence. © 2016 AEU
Showing items related by title, author, creator and subject.
ArticleGarcia-Gordillo M.A.; Collado-Mateo D.; Olivares P.R.; Adsuar J.C. (Springer Verlag, 2018)
Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish Health Survey, 2011 (2020) Garcia-Gordillo M.A.; Adsuar J.C.; Olivares P.R. (Springer International Publishing, 2016)
Normative values of SF-6D questionnaire for chilean diabetes patients [Datos normativos del cuestionario SF-6D en pacientes diabéticos chilenos] (2020) García-Gordillo M.A.; Collado-Mateo D.; Olivares P.R.; Adsuar J.C. (Grupo Aula Medica S.A., 2015)